Migraine News and Research

Latest Migraine News and Research

Mylan confirms Frova patent challenge

Mylan confirms Frova patent challenge

Link between brain shrinkage, memory loss in Alzheimer's changes across age spectrum

Link between brain shrinkage, memory loss in Alzheimer's changes across age spectrum

Neurologist care may improve quality of life for people with Parkinson's

Neurologist care may improve quality of life for people with Parkinson's

U.S. District Court rules in favor of POZEN in Treximet patent litigation

U.S. District Court rules in favor of POZEN in Treximet patent litigation

Allergan receives positive opinion from Irish Medicines Board for BOTOX

Allergan receives positive opinion from Irish Medicines Board for BOTOX

Longer looks: Treating Down syndrome?; mentally ill, meds & trials

Longer looks: Treating Down syndrome?; mentally ill, meds & trials

FDA accepts MAP Pharmaceuticals' LEVADEX NDA for filing

FDA accepts MAP Pharmaceuticals' LEVADEX NDA for filing

Smoking, high blood pressure and diabetes in middle age linked to brain damage

Smoking, high blood pressure and diabetes in middle age linked to brain damage

Statins may help protect young people from future strokes

Statins may help protect young people from future strokes

Merck reports worldwide sales of $12.2 billion for second quarter 2011

Merck reports worldwide sales of $12.2 billion for second quarter 2011

POZEN reports revenue of $4.6 million for second quarter 2011

POZEN reports revenue of $4.6 million for second quarter 2011

Cognitive behavioral therapy and self-help may improve unexplained symptoms of pain, fatigue

Cognitive behavioral therapy and self-help may improve unexplained symptoms of pain, fatigue

Safeguard Scientifics reports consolidated net income of $121.8M for second quarter 2011

Safeguard Scientifics reports consolidated net income of $121.8M for second quarter 2011

Baxter GAMMAGARD LIQUID for PI receives FDA approval for subcutaneous administration

Baxter GAMMAGARD LIQUID for PI receives FDA approval for subcutaneous administration

FDA approves Cephalon's REMS for FENTORA, ACTIQ

FDA approves Cephalon's REMS for FENTORA, ACTIQ

Public disclosure of Bachmann's migraine condition raises much-needed awareness

Public disclosure of Bachmann's migraine condition raises much-needed awareness

Study examines cost-effectiveness of MS drugs in the U.S.

Study examines cost-effectiveness of MS drugs in the U.S.

Scientists analyze structural changes in calcium channels caused by Timothy-mutation

Scientists analyze structural changes in calcium channels caused by Timothy-mutation

Maintaining general health may help reduce risk for dementia

Maintaining general health may help reduce risk for dementia

UW scientists determine atomic architecture of sodium channel

UW scientists determine atomic architecture of sodium channel

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.